Travere Therapeutics, Inc. TVTX Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s other noncash income (expense)?
- Travere Therapeutics, Inc. (TVTX) reported other noncash income (expense) of $4K in Q1 2026.
- How has Travere Therapeutics, Inc.'s other noncash income (expense) changed year-over-year?
- Travere Therapeutics, Inc.'s other noncash income (expense) decreased by 99.7% year-over-year, from $1.57M to $4K.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.